US Dollar vs MXN

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

IRON

Disc Medicine (IRON)

Disc Medicine Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IRON

1 2 3 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
13/05/2024	07:00	GlobeNewswire Inc.	Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference	NASDAQ:IRON	Disc Medicine Inc
09/05/2024	07:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IRON	Disc Medicine Inc
09/05/2024	07:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRON	Disc Medicine Inc
09/05/2024	07:00	GlobeNewswire Inc.	Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:IRON	Disc Medicine Inc
01/04/2024	07:00	GlobeNewswire Inc.	Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)	NASDAQ:IRON	Disc Medicine Inc
21/03/2024	07:00	GlobeNewswire Inc.	Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:IRON	Disc Medicine Inc
06/03/2024	15:30	GlobeNewswire Inc.	Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024	NASDAQ:IRON	Disc Medicine Inc
01/03/2024	18:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
26/02/2024	07:30	GlobeNewswire Inc.	Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer	NASDAQ:IRON	Disc Medicine Inc
20/02/2024	07:30	GlobeNewswire Inc.	Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease	NASDAQ:IRON	Disc Medicine Inc
15/02/2024	15:22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
13/02/2024	17:51	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:IRON	Disc Medicine Inc
09/02/2024	08:00	GlobeNewswire Inc.	Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia Vera	NASDAQ:IRON	Disc Medicine Inc
07/02/2024	07:00	GlobeNewswire Inc.	Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer	NASDAQ:IRON	Disc Medicine Inc
03/01/2024	16:00	GlobeNewswire Inc.	Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:IRON	Disc Medicine Inc
20/12/2023	15:30	GlobeNewswire Inc.	Disc Medicine Announces Retirement of Brian MacDonald, MB, ChB, PhD as Chief Innovation Officer and Appointment as Chair of Scientific Advisory Board	NASDAQ:IRON	Disc Medicine Inc
11/12/2023	19:30	GlobeNewswire Inc.	Disc Presents Positive Updated Results from Phase 2 BEACON Study of Bitopertin and Other Programs at the 65th American Society of Hematology (ASH) Annual Meeting	NASDAQ:IRON	Disc Medicine Inc
11/12/2023	11:00	GlobeNewswire Inc.	Disc Presents Initial Positive Data from Ongoing Phase 1b/2 Trial of DISC-0974 in Patients with Myelofibrosis (MF) and Anemia at the 65th American Society of Hematology (ASH) Annual Meeting	NASDAQ:IRON	Disc Medicine Inc
06/12/2023	23:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:IRON	Disc Medicine Inc
05/12/2023	15:53	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:IRON	Disc Medicine Inc
05/12/2023	15:51	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:IRON	Disc Medicine Inc
14/11/2023	15:44	GlobeNewswire Inc.	Disc Medicine Announces Grant of US Patent for Methods of Treating Erythropoietic Protoporphyrias with Bitopertin	NASDAQ:IRON	Disc Medicine Inc
13/11/2023	05:46	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:IRON	Disc Medicine Inc
09/11/2023	07:30	GlobeNewswire Inc.	Disc Medicine Reports Third Quarter 2023 Financial Results and Provides Business Update	NASDAQ:IRON	Disc Medicine Inc
08/11/2023	15:30	GlobeNewswire Inc.	Disc Medicine to Participate in Upcoming Investor Conferences	NASDAQ:IRON	Disc Medicine Inc
02/11/2023	08:00	GlobeNewswire Inc.	Disc Medicine Announces Multiple Presentations Across Portfolio at the 65th American Society of Hematology Annual Meeting and Key Program Updates	NASDAQ:IRON	Disc Medicine Inc
23/10/2023	08:15	GlobeNewswire Inc.	Disc Medicine Announces Planned Departure of Chief Financial Officer Joanne Bryce	NASDAQ:IRON	Disc Medicine Inc
03/10/2023	07:30	GlobeNewswire Inc.	Disc Medicine Initiates a Phase 1 Study of DISC-3405 (anti-TMPRSS6 mAb) in Healthy Volunteers	NASDAQ:IRON	Disc Medicine Inc
25/09/2023	15:56	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:IRON	Disc Medicine Inc
20/09/2023	16:18	Dow Jones News	Disc Medicine Polycythemia Vera Treatment MWTX-003 Gets FDA Fast Track Designation	NASDAQ:IRON	Disc Medicine Inc

Showing the most relevant articles for your search:NASDAQ:IRON

1 2 3 Próxima >

Verizon Communications

American Express

Invesco QQQ Trust Series 1

Financial Select Sector

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones